Rheumatology
-
Heart risk reducing for rheumatoid arthritis patients
Patients with rheumatoid arthritis have been enjoying a reduction in risk of cardiovascular disease since the turn of the century, a conference has heard. Read more
-
Drugs reducing RA demand for surgery, conference hears
The use of biological drugs can reduce the need for knee and hip replacements, a European conference has heard. Read more
-
Pre-RA treatment backed at Euro-conference
Active treatment of patients thought to be developing rheumatoid arthritis successfully staves of disease development, a European conference has heard. Read more
-
Chondroitin sulfate "effective" knee treatment
Treatment of knee osteoarthritis with chondroitin sulfate is equally effective as non-steroidal anti-inflammatory drugs, researchers say today. Read more
-
Hope to tackle age-related diseases
A genetic breakthrough will pave the way for a range of new drugs to tackle age-related diseases, it was claimed last night. Read more
-
Metabolism gene origins unveiled
Swedish scientists have unveiled new findings about a gene thought to play a key role in human metabolism. Read more
-
Fibroblast study offers RA clue
Fibroblasts may prove an effective new target for treatments of rheumatoid arthritis, according to British researchers. Read more
-
Giant genetic leap for Europe
European researchers have revealed the findings of a major project that set out to investigate links between blood cell development and a range of disease. Read more
-
Epilepsy link to maternal RA
Women with rheumatoid arthritis face an increased risk of having children who develop epilepsy, Danish researchers have reported. Read more
-
Blood test for early osteoarthritis diagnosis
A new test that could diagnose early-stage arthritis several years before the onset of physical and irreversible symptoms could be available within two years. Read more